JMP

SpringLeaf Holdings Inc (NYSE: LEAF) beat Q3 EPS expectations Friday and the stock surged 4 percent Monday, trading at $38.01. Several analysts increased their price targets. Below are highlights along with current ratings and price targets. JMP Securities - Outperform, price target...

Tableau Software Inc (NYSE: DATA) reported Q3 financials Wednesday with strong results. The stock spiked Thursday and was trading at $84.50 on Friday, up 0.38 percent. Analysts had positive comments for the company. Below are current analyst ratings and price targets. Cantor - Buy, $...

Google Inc (NASDAQ: GOOGL) shares continued to fall Friday as Wall Street trimmed earnings forecasts in the wake of the company's third-quarter earnings miss. After the bell Thursday the company told investors that its third-quarter "paid clicks" growth slowed to 15 percent from...

Salix Pharmaceutical's (NASDAQ: SLXP) $2.7 billion inversion deal disappointed investors Wednesday who complain it dilutes near-term earnings and makes Salix seem like an unlikely merger candidate any time soon. Salix said after the bell Tuesday it will acquire the Irish unit of Italy's...

Shares of Rackspace (NYSE: RAX) jumped higher after the company reported a 50 percent EPS beat and strong forward guidance. Tuesday, analysts from FBN, JMP, Pacific Crest and Raymond James gave their opinions of the results. FBN: Maintains Underperform Rating, Lowers Price Target to $30 FBN...

JMP & Needham suggest that Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is not likely to see other offers following the Lundneck bid. JMP analyst Jason Butler called Chelsea Therapeutics sale process “thorough” and sees a competing bid as “unlikely.” Butler added that the company's...